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Objective: Obtain utilities (preferences) for a generalizable set of health states experienced by older children and
adolescents who receive therapy for chronic health conditions.
Methods: A health state classification system, the Adolescent Health Utility Measure (AHUM), was developed based
on generic health status measures and input from children with Hunter syndrome and their caregivers. The AHUM
contains six dimensions with 4–7 severity levels: self-care, pain, mobility, strenuous activities, self-image, and health
perceptions. Using the time trade off (TTO) approach, a UK population sample provided utilities for 62 of 16,800
AHUM states. A mixed effects model was used to estimate utilities for the AHUM states. The AHUM was applied to
trial NCT00069641 of idursulfase for Hunter syndrome and its extension (NCT00630747).
Results: Observations (i.e., utilities) totaled 3,744 (12*312 participants), with between 43 to 60 for each health state
except for the best and worst states which had 312 observations. The mean utilities for the best and worst AHUM
states were 0.99 and 0.41, respectively. The random effects model was statistically significant (p < 0.0001; adjusted
R2 = 0.361; RMSE = 0.194). When AHUM utilities were applied to the idursulfase trial, mean utilities in the idursulfase
weekly and placebo groups improved +0.087 and +0.006, respectively, from baseline to week 53. In the extension,
when all patients received idursulfase, the utilities in the treatment group remained stable and the placebo group
improved +0.039.
Discussion: The AHUM health state classification system may be used in future research to enable calculation of
quality-adjust life expectancy for applicable health conditions.Introduction
An important innovation in cost effectiveness analysis in
health care has been the development of the quality
adjusted life year (QALY) that combines longevity with
quality of life. It achieves this by assigning a preference
value (utility weight) to each health state experienced by
a patient on a scale where 0.0 reflects being dead and
1.0 reflects full health [1]. Evaluation of the incremental
cost per QALY gained, or cost-utility analyses, is now a
standard type of cost-effectiveness analysis [2,3].
The last decade has seen increasing use made of gen-
eric utility measures that are assigned preference weights
based on the general population perspective, as recom-
mended by the US Panel on Cost-Effectiveness in Health
and Medicine and used by the National Institute for* Correspondence: kathy.beusterien@oxfordoutcomes.com
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reproduction in any medium, provided the orHealth and Clinical Excellence (NICE) [4,5]. Examples of
such measures include the EQ-5D and the SF-6D [6,7].
These are multi-attribute scales based on a generic
health state classification where health is described
across multi-level dimensions of health applicable across
different health conditions. These measures come with a
set of preference weights obtained from members of the
general public using a preference elicitation technique
like the time trade off (TTO) approach. All such multi-
attribute measures, however, have descriptive systems
that are derived from adult populations with the excep-
tion of the Heath Utility Index Mark 2, and thus add-
itional attributes that are particularly relevant to child
health, including autonomy and body image, may not be
captured [2].
Based on a critical review of published cost-utility
studies in child health, among the approaches cited for
implementing cost-utility analysis in pediatric popula-
tions include the explicit development of a genericd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adult populations [2]. The objective of the current study
was to develop a multi-attribute measure, the adolescent
health utility measure (AHUM), that focuses on key
impacts of treatment for chronic conditions among older
children and adolescents. Researchers would then be
able to use this measure, either prospectively collecting
AHUM data or mapping the AHUM utilities to patient-
reported outcomes (PRO) measure data that already
have been collected, to quality-adjust life expectancy in
future economic evaluations that involve interventions
for chronic conditions that may be experienced in
childhood.
Methods
Development of the AHUM involved three steps. The
first step was the selection of the health attributes and
respective levels, which, in different combinations, char-
acterized the AHUM health states. The second step was
to obtain values (utility weights) for a sample of AHUM
health states from the general adult population, as pre-
ferred by NICE. The third step was to develop a statis-
tical model to estimate mean values for all of the
AHUM health states. Finally, we applied the AHUM to a
clinical trial sample of children with Hunter syndrome
and compared AHUM utility scores over time between
the treatment (idursulfase) and placebo groups.
Selection of AHUM attributes
In selecting the attributes (dimensions) for the AHUM,
we considered the concepts captured by common gen-
eric measures such as the EQ-5D (mobility, self-care,
usual activities, pain/discomfort and anxiety/depression)
and the SF-6D (physical functioning, role limitations,
social functioning, bodily pain, mental health, and tired-
ness/vitality). In addition, a review of the literature fo-
cusing on impacts of childhood conditions identified
key respective concerns. Specifically, Norrby and collea-
gues [8] used the Child Health Questionnaire (CHQ)
to evaluate health-related quality of life among chil-
dren with asthma, diabetes, juvenile chronic arthritis,
or short stature. The CHQ scales showing detrimental
effects that varied across conditions included physical
functioning, bodily pain, self-esteem, and general
health. Another study of adolescents with short stature
showed that they may experience detriments in per-
ceived competence at school, athletic ability, and trait
anxiety [9].
In addition to this review, disease impacts identified
by children (and caregivers) with Hunter syndrome
informed the identification of the AHUM domains.
Obtaining input from children with Hunter syndrome
was useful because this condition has potentially wide-
ranging impacts on health-related quality of life.Specifically, Hunter syndrome can cause coarse facial
features, cardiovascular disorders, short stature, joint
stiffness, skeletal deformities and mental retardation;
eventually, patients become wheelchair-bound and venti-
lator dependent [10]. A total of 27 parents and 11 sub-
jects with Hunter syndrome between 12 and 18 years of
age were interviewed on the impacts of Hunter syn-
drome and treatment on daily life. Based on these inter-
views, key topics or themes were identified through
qualitative analysis of the data. Specifically, the main
areas of health identified by the children and caregivers
were problems with: 1) lower body tasks such as walking
(mobility); 2) upper body tasks such as eating, buttoning
a shirt (self-care, e.g., dressing etc.); 3) sleeping; 4)
schoolwork; 5) dissatisfaction with physical activities/
sports; 6) breathing; and 7) satisfaction with current
treatment/perception of making progress on treatment.
Based on these concepts and those identified in the
literature, six dimensions with different respective se-
verity levels were identified for the AHUM health state
classification system: self-care, pain, limitations in
walking around (mobility), perception of ability to do
strenuous activities, self-image, and health perceptions
(current health and health compared to one year ago
(Table 1). These concepts were those identified in the
qualitative research, with the exception of sleeping,
schoolwork, breathing, and trait anxiety, which were
determined to be too narrowly focused for inclusion in
a health state classification system capturing overall
health-related quality of life. The selected AHUM con-
cepts were augmented with self-image and pain, two
concepts that were identified in the literature review,
and the latter of which appears in both the SF-6D and
EQ-5D. The AHUM domains and levels utilize similar
concepts, adapted to the present tense, as those used
in existing general health status questionnaires, such as
the 20-item Medical Outcomes Study (MOS) question-
naire (RAND), 36-item Short-Form Health Survey,
CHQ, and the more specific Rosenberg Self-Esteem
scale [11-14]).
The omission of a dimension focusing on anxiety or
emotional impact was intentional. During utility elicit-
ation exercises like time trade off (TTO), respondents
are asked to value being in different health states. We
believe that, inherent in such evaluations is consider-
ation of the emotional distress of being in the selected
health state, and thus the respective emotional impact
would be factored into the ultimate utility value for
the selected health state. As such, adding a dimension
on anxiety to the health state classification system
would be redundant. We do not wish to dictate how
much anxiety or distress a subject attaches to the dif-
ferent AHUM health states; rather, we anticipate that
this emotional impact is reflected in the utility values.
Table 1 AHUM Health State Classification System
Level Descriptions
Self-care
1 You are not limited in eating, dressing, bathing,
or using the toilet
2 You are limited a little in eating, dressing, bathing,
or using the toilet
3 You are limited moderately in eating, dressing, bathing,
or using the toilet
4 You are limited a lot in eating, dressing, bathing,
or using the toilet
Pain
1 You have no pain
2 You have very mild pain
3 You have mild pain.
4 You have moderate pain
5 You have severe pain
6 You have very severe pain
Limitations walking around (mobility)
1 You are not limited in walking around
or going to school/work
2 You are limited a little in walking around
or going to school/work
3 You are limited moderately in walking around
or going to school/work
4 You are limited a lot in walking around
or going to school/work
Perceptions of strenuous activities
1 You feel very good about your ability to do
strenuous activities (like running or participating in sports).
2 You feel somewhat good about your ability to do
strenuous activities (like running or participating in sports).
3 You feel neutral (neither good or bad) about your ability to do
strenuous activities (like running or participating in sports).
4 You feel somewhat bad about your ability to do
strenuous activities (like running or participating in sports).
5 You feel very bad about your ability to do
strenuous activities (like running or participating in sports).
Self-image
1 On the whole, you feel very good about your body.
2 On the whole, you feel somewhat good about your body.
3 On the whole, you feel neutral (neither good or bad)
about your body.
4 On the whole, you feel somewhat bad about your body.
5 On the whole, you feel very bad about your body.
Health perceptions
1 Your health is better now than one year ago, and you feel
like you are in very good to excellent health.
2 Your health is better now than one year ago, and you feel
like you are in good health.
3 Your health is the same now as one year ago, and you feel
like you are in very good to excellent health.
Table 1 AHUM Health State Classification System
(Continued)
4 Your health is the same now as one year ago, and you feel like
you are in good health.
5 Your health is about the same or somewhat better now than
one year ago, and you feel like you are in fair or poor health.
6 Your health is worse now than one year ago, and you feel l
ike you are in good to excellent health.
7 Your health is worse now than one year ago, and you feel
like you are in fair or poor health.
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The different combinations of the attribute levels in
Table 1 (e.g., 111111, 121133, etc.) reflect different pos-
sible health states; the classification system defines
16,800 health states. To estimate utility weights (prefer-
ence values) for these health states, a cross-sectional sur-
vey was conducted in the UK general population using
the time trade-off (TTO) approach. The TTO exercise is
a widely accepted technique that yields preference
weights on a scale from 0.0, reflecting being dead, to 1.0,
reflecting full health [15]. The target sample was 300
people in the UK general population (England and
Scotland). Six trained interviewers located in England
and Scotland recruited study participants through word-
of-mouth and the Oxford Outcomes’ general population
panel. All study participants met the following eligibility
criteria: resident of UK, 18 years of age or older, ad-
equate written and oral fluency in English, and willing
and able to provide written informed consent. All study
participants were compensated £25 for their time. The
study protocol was approved by Independent IRB (Plan-
tation, FL, USA).
Given the vast number of possible health states that
can be derived from the different combinations of levels
across the AHUM domains, an orthogonal subset of 49
health states generated by Orthoplan in SPSS, as well as
an additional 11 randomly selected states, were selected
for inclusion in the TTO interviews. Each interview
included obtaining utilities for 12 health states, including
10 of the 60 selected health states plus the best state
(most favorable level of each domain: 111111) and the
worst state (least favorable level of each domain:
464557). The best health state was included in the exer-
cise to evaluate the magnitude of the difference in utility
values between this state and full health. To increase
precision in utility estimation for each state, the plan
was to obtain values from at least 40 study participants
for each health state. As discussed by Brazier et al.
[16,17], the average values obtained from 10 respondents
are likely to be very unreliable. With a target sample size
of 300, the 6 study interviewers could administer sets of
10 unique health states to at approximately 33 study par-
ticipants, yielding at least 40 TTO values for each health
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than numbers to avoid imposing any kind of hierarchy
with respect to their order.
During the TTO interviews, subjects were first asked
to review 13 health states (10 assigned health states, the
best and worse health state, and full health) and rank
them from most favorable to least favorable to help
familiarize the participant with the health states. Subse-
quently, for each health state (except for full health), the
TTO exercise was conducted; the health states were
shuffled, randomizing the order in which the health
states were presented. Specifically, for each state, the re-
spondent was asked to imagine living in the health state
as described for 10 years or they can trade off some time
to live in full health. The objective of the interview is to
identify the maximum amount of the 10 years the re-
spondent is willing to trade off to live in full health. The
interviewer followed a standardized interview guide and
used a prop to illustrate the comparison between the
number of years in the selected health state and the
number of years in full health. To minimize starting
point bias, the time traded-off was alternated in 1 year
increments from the most extreme to least extreme;
once the number of years was identified, the interviewer
further probed using months. In the TTO interviews,
subjects sometimes found particular health states hard
to imagine because of seemingly contradictory domain
levels (e.g., how can you be very limited in walking
around or going to school, yet feel that you are in good
to excellent health?). In these scenarios, participants
were asked to focus on those dimensions that mattered
the most to them and try their best to imagine the
scenario.
To calculate the health utility for each health state, the
maximum number of years that the respondent was will-
ing to trade off to live in full health was subtracted from
10 and this result was divided by 10 to arrive at the util-
ity of the health state, where a score of 0.0 score reflects
being dead, and a 1.0 score reflects full health. It should
be noted that utilities may be worse than being dead
(i.e., utilities can have negative values); however, the
TTO approach used in this study did not allow for
health states to be rated as worse than being dead as it
was thought that this would occur only rarely; thus, no
negative utilities were obtained. If a respondent consid-
ered a health state as worse than being dead, the health
state was assigned a utility of 0.
Modeling health state values
The aim of developing a model was to enable the esti-
mation of all possible health states (all the possible com-
binations of levels) that can be derived from the AHUM
health state classification system, which yields 16,800
unique health states. A mixed effects model wasperformed that included fixed effects for the levels of
each AHUM domain and random effects for each sub-
ject. The model also included a fixed effect interaction
term for being at the worse level of any domain, which
is a common method to allow for non-linearities in
modeling preference data [6,7,16,17]. Thus, the model
included 26 fixed effects in total. No variables other than
the AHUM levels and the subject were included in the
model. Analyses were performed using SAS v9.2.
Application of AHUM utilities to pediatric clinical trial
The model for estimation of AHUM utilities was applied
to a phase II/III, randomized, double-blind, placebo-
controlled 53-week study (NCT00069641) evaluating
the safety and efficacy of weekly and every other week
dosing regimens of iduronate-2-sulfatase enzyme re-
placement therapy in patients with Hunter syndrome
[18] and its extension study (NCT00630747) [19]. In
conjunction with this trial, the parent version of the
Child Health Questionnaire (CHQ) was administered
[11].
Seven items from the parent CHQ that reflect similar
content as that comprised in the AHUM health state
classification system were used for assignment of
AHUM utilities. Specifically, the concepts captured by
the mapped CHQ items include eating, dressing, bath-
ing, or going to the toilet; bodily pain or discomfort;
ability to get around the neighborhood, playground, or
school; satisfaction with athletic ability; general health;
health rating now compared to 1 year ago; and satisfac-
tion about looks/appearance. The selected CHQ item
responses are similar to the levels of the AHUM with
the exception of those for satisfaction with athletic abil-
ity and satisfaction with looks/appearance; in the CHQ,
the respective responses range from ‘very satisfied’ to
‘very dissatisfied’. The responses to these items were in-
putted into the model to estimate utilities for each pa-
tient at each assessment time-point. The mean utilities
for each treatment group were calculated for each time-
point that the questionnaire was administered: baseline,
18, 36, and 53 weeks. At 53 weeks, all patients continued
on weekly idursulfase therapy (placebo patients
switched), and the questionnaires were again adminis-
tered at 71, 89, 105, 133, and 157 weeks follow-up.
Results
A total of 312 individuals in the UK participated in and
completed the TTO interviews yielding 3,744 (12*312)
observations (i.e., utilities), between 43 to 60, for each
health state except for the best and worst states which
had 312 observations. Based on the TTO utilities, among
the 312 participants, 38 rated one of the health states in
the interview as worse than the worst health state
(464557), and 9 participants rated one of the health
Table 2 Demographics of Study Population (N=311)
Demographics N (%)
Total no. of cities represented 47
Sex (n = 311)
Female 144 (46.3%)







Education (n = 309)
< 5 GCSE 37 (12.0%)
5 GCSE 32 (10.4%)
2 A/AS 91 (29.4%)
Degree+ 149 (48.2%)





Relationship status (n = 310)
Married/partner 170 (55.0%)
Single 140 (45.0%)
Have children< 18 years (n = 309)
Yes 140 (20.7%)
No 170 (79.3%)
Occupation (n = 310)
Full time 127 (41.0%)
Part time 28 (9.0%)
Student 102 (32.9%)
Retired 14 (4.5%)
Stay at home 10 (3.2%)
Other 29 (9.4%)
Co-morbid conditions (n = 311)
Respiratory conditions 13 (4.2%)
GI problems 12 (3.9%)
Other chronic conditions 52 (16.7%)
No Chronic conditions 234 (75.2%)
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tient considered one health state, and another consid-
ered two health states, as worse than being dead, and
thus these states were assigned a utility of 0.0. All parti-
cipants who provided illogical ratings were included in
the modeling exercise; one participant was excluded
from the analysis given that, because of religious rea-
sons, the person did not want to make choices with re-
spect to trading time off to avoid being in hypothetical
health states.
Table 2 reports the demographic characteristics of the
study sample (N = 311). The participants live in a total of
47 different cities representing geographical spread
across the UK. A total of 41% work full time, 42% are
single, and 21% have children, and 25% have a chronic
condition. A comparison of the sample statistics those
reported in the UK census 2001 [20] showed that the
study sample was disproportionately younger, with
24.9% versus 7.8% in the 20–24 year old age group
observed in the study sample versus the census results,
respectively. In addition, a higher proportion of partici-
pants in the study attained a higher education level than
those reported in the census (48% vs. 27%).
Table 3 reports the mean rankings for each of the
health states (participants were asked to rank order the
health states from most to least favorable before they
were asked the TTO questions) and the respective
mean utilities for a sample of AHUM health states. As
shown, the utilities generally become less favorable
(lower) with lower rankings. The average utilities for
the best health state (111111) and worse health state
(454577) were 0.99 and 0.41, respectively. The utility
for 111111 of 0.99 helps confirm that this state and full
health largely were comparable. A utility of 0.41 for the
worse health state means that the respondents would
be willing to trade off 59% of their time remaining to
avoid being in the worse health state. Of the 62 health
states for which utilities were obtained, 12 were rated
as bad as being dead (utility = 0.0) by at least one par-
ticipant (3 states were considered as worse than death).
All health states with a utility of 0.0 were included in
the statistical model.
Statistical model
The first iteration of the mixed effects model showed
the coefficients for ‘you feel neutral about your ability to
do vigorous activities’ (level 3) and ‘you feel somewhat
bad about your ability to do vigorous activities’ (level 4)
to be the same, and thus these 2 levels were combined
for the final model, which overall was statistically signifi-
cant (p < 0.0001; adjusted R2 = 0.361; RMSE= 0.194).
With respect to the AHUM classification system, the
dimensions clearly worsen with each subsequent level
except for health perceptions, in which each level hastwo concepts (health compared to one year ago and
current health status) that may impact preferences
differently.a The model showed that the coefficients
differed in the expected direction across the levels of
the five dimensions that have expected differences in
severity except for two coefficients, the 3rd level of
Table 3 Rankings and Time Trade Off utilities for sample of AHUM health states
AHUM Health state rankings TTO utilities
Health state N Mean Median Mean SD Min Max Median
Full health 311 1.04 1 - - - - -
111111 311 2.02 2 0.99 0.06 0.10 1.00 1.00
111331 48 3.08 3 0.96 0.11 0.43 1.00 1.00
113244 60 3.67 3 0.94 0.10 0.55 1.00 0.98
131123 53 4.34 4 0.93 0.09 0.60 1.00 0.98
133322 43 4.40 4 0.91 0.12 0.50 1.00 0.98
222343 43 4.86 4 0.90 0.15 0.40 1.00 0.98
321412 43 4.91 5 0.89 0.14 0.50 1.00 0.95
222221 48 5.06 4 0.89 0.15 0.28 1.00 0.95
132213 53 5.08 5 0.92 0.09 0.70 1.00 0.95
211126 51 5.27 5 0.92 0.11 0.63 1.00 0.95
121142 53 5.32 5 0.91 0.14 0.40 1.00 0.95
312112 56 5.48 5 0.88 0.16 0.10 1.00 0.95
112435 56 5.77 5 0.90 0.15 0.10 1.00 0.95
212213 51 5.80 4 0.90 0.11 0.60 1.00 0.93
121146 51 5.84 6 0.87 0.17 0.20 1.00 0.93
211244 56 6.14 6 0.90 0.15 0.10 1.00 0.95
313221 51 6.25 5 0.86 0.14 0.50 1.00 0.90
331247 43 6.26 6 0.79 0.20 0.30 1.00 0.83
313236 48 6.31 6 0.85 0.18 0.30 1.00 0.93
131363 51 6.45 7 0.85 0.16 0.40 1.00 0.90
241232 56 6.52 6.5 0.88 0.16 0.10 1.00 0.95
113522 53 6.60 6 0.87 0.17 0.10 1.00 0.95
434131 60 6.83 6.5 0.76 0.21 0.20 1.00 0.80
253115 60 6.88 6.5 0.71 0.24 0.00 1.00 0.80
211154 56 6.95 6.5 0.88 0.15 0.10 1.00 0.93
412427 60 6.97 6.5 0.78 0.20 0.23 1.00 0.82
221242 51 7.14 7 0.85 0.16 0.30 1.00 0.93
441225 60 7.20 7 0.76 0.22 0.15 1.00 0.84
232434 56 7.23 7 0.85 0.18 0.10 1.00 0.90
342314 56 7.50 8 0.82 0.19 0.10 1.00 0.90
252326 60 7.57 8 0.73 0.23 0.00 1.00 0.80
TTO= Time trade off.
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neutral about body, which were slightly higher (lower
disutility) than those for the coinciding less severe
levels, respectively. Table 4 shows an example of how
the model is used to compute the AHUM utility weight
for health state 214524.
Application to a pediatric clinical trial
The clinical trial used in this study was NCT00069641
(A phase II/III, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of
weekly and every other week dosing regimens of
iduronate-2-sulfatase enzyme replacement therapy in
patients with MPS II) and its extension study. The ran-
dom effects model was used to assign utilities to patients
at each assessment time-point in the enzyme replace-
ment therapy trial [18,19]. Specifically, the parent-
completed version of the CHQ was administered during
the trial, and seven items from this questionnaire that
reflect similar content as that comprised in the AHUM
Table 4 Computing AHUM utility for health state 214524
Dimension
level
Health state description Beta
coefficient
2 You are limited a little in eating,
dressing, bathing, or using the toilet.
−0.028
1 You have no pain. −0.0
4 You are limited a lot in walking around
or going to school/work.
−0.085
5 You feel very bad about your ability
to do strenuous activities (like running or
participating in sports).
−0.076
2 On the whole, you feel somewhat good
about your body.
−0.007
4 Your health is the same now as
one year ago, and you feel
like you are in good health.
−0.015
Equation for calculating AHUM utility for health state 214524.
AHUM utility = 0.976 (intercept) – 0.028 – 0.0 – 0.085 – 0.076 – 0.007 – 0.015
AHUM utility = 0.765.
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ment of AHUM utilities. Figure 1 shows the average util-
ity by week from the perspective of the total population.
The mean utilities in the idursulfase weekly group im-
prove from 0.78 at baseline to 0.87 at week 53 (differ-
ence = +0.087), whereas the utilities in the placebo group
improved from 0.79 to 0.80 (difference = +0.006). At
baseline, the mean between the two groups were not sig-
nificantly different from each other (p = 0.73). However,
the group means were significantly different from each
other at weeks 18, 36 and 53 (p < 0.03). In the extension
phase, the mean utilities in the idursulfase weekly group
remained stable over time, whereas the placebo group,
which transitioned onto idursulfase therapy during this
period, improved from 0.80 at week 53 to 0.84 at week
157 (difference = +0.039). It should be noted that utilityFigure 1 AHUM Utilities Assigned to Pivotal & Extension Idursulfase T
treatment group differences in mean average utility at weeks 18, 36, & 53.weights reflect preference values and represent only one
of the many types of outcomes that may be used to as-
sess the effectiveness of treatment.
Discussion
The findings from this research yielded a health state
classification system, the Adolescent Health Utility
Measure (AHUM), that describes key impacts of having
a chronic condition from the perspective of children or
adolescents. The impacts largely overlap with those cap-
tured in other health state classification measures such
as the SF-6D and EQ-5D, but also include self-image
and health perceptions. As such, although Hunter syn-
drome patients were interviewed to ensure that the
AHUM was comprehensive with respect to covering
key areas of health from the child and adolescent per-
spective, the AHUM may be useful for other health
conditions affecting children and adolescents. AHUM
utilities may be used to quality-adjust life expectancy
in future cost-effectiveness evaluation of pediatric med-
ical interventions.
The AHUM dimensions comprise self-care, bodily
pain, limitations in walking around or going to school/
work, perceptions of ability to do vigorous activities,
self-image, and perceptions about current health in rela-
tion to the past. As found in previous studies [6,7], these
concepts have been shown to be impacted among chil-
dren with chronic conditions. Based on the parameter
estimates in the AHUM model, the two dimensions that
appeared to be most important from the respondents’
perspectives were self care and bodily pain. For these
dimensions, all severity levels, even the mildest, were
statistically significant. Consistent with this finding, the
EQ-5D disabilities associated with pain are highest
(worse) for pain relative to the other dimensions.rial (Weeks 0 to 157): Perspective of UK Population. *p < 0.03 for
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interviews in which children and their caregivers agree
that satisfaction with current treatment/perception of
making progress on treatment is important, the AHUM
dimension, health perceptions, includes a description of
the individual’s condition now compared to a year ago,
which would be an indication of how the patient with a
chronic condition is faring on treatment. Although this
refers to the experience relative to one year ago, which
cannot be measured absolutely, we believe that this is a
critical element in fully capturing an individual’s percep-
tion of current health, particularly when one has a
chronic condition and is on treatment. Previous studies
have shown that knowledge that one is responding to
treatment as opposed to getting worse, can significantly
influence utility weights [21,22]. Poor health perceptions
likely can lead to greater anxiety, which has been found
to be an important concept among children with chronic
conditions. For example, a study that used the General
Health Questionnaire in a psychological assessment of
children with mucopolysaccharidosis type II confirmed
that patients and their parents had higher levels of anx-
iety [23].
A limitation in this study is that respondents were not
able to rate health states as worse than death (reflected
by a score of 0.0). Health states such as dementia and
coma have been previously shown to be rated worse
than death by some respondents [24]. Single index
scores of the Health Utility Index (HUI) and the EQ-5D
allow predicted utilities to be less than 0.0 [6,25]. The
HUI2 and HUI3’s worst utilities that can be calculated
are −0.03 and - 0.36, respectively [22]. In contrast, the
AHUM’s worst utility weight that can be calculated is
0.419. It also should be noted that the system is based
on utilities obtained from the UK population; it is pos-
sible that utility weights may vary across countries. Also,
in this study the members of the general public who
provided utilities were disproportionately younger com-
pared to the general UK population as surveyed in 2001.
Finally, the Health Perceptions domain does not capture
all the possible combinations of health today and health
last year. For future use of the AHUM, it may be useful
to make assumptions a priori as to the assignment of
utilities to this domain.
With respect to multi-attribute general health status
measures, the breadth of the content typically must be
limited to key concepts that broadly capture overall
health-related quality of life. Similar to other multi-
attribute measures, the AHUM includes key concepts
that together capture overall health-related quality of
life. A limitation in this study is that the AHUM
domains and levels were not tested for content validity
before implementation. Nevertheless, the items used in
the classification system focus on concepts that areincorporated into numerous patient reported outcomes
measures that have shown evidence that they are meas-
uring the concepts they are intending to measure. The
AHUM may be administered to both adults and younger
subjects; however, if the AHUM will be administered to
children or adolescents, then it would be useful to per-
form pilot testing, specifically cognitive debriefing inter-
views, in this population, and revise the content as
necessary to ensure that the measure is understood and
interpreted as expected before study implementation.
Further research on the AHUM classification system
would be useful, including an evaluation of the prefer-
ence weights based on the perspective of an adolescent
population rather than an adult population. It also would
be useful to perform further research evaluating prefer-
ences for the AHUM health states in other countries
where cost-effectiveness evaluations are increasingly
being used to inform clinical decision making.
In conclusion, although the AHUM was developed to
capture key content that may be important among older
children and adolescents, this new health state classifica-
tion system should apply to conditions given that the de-
scriptive system is valid in such populations. Given that
a generalizable set of health states were used, the
AHUM may serve as a useful tool to derive utilities for
economic evaluations of a wide range of treatments.
Endnotes
aThe scoring algorithm for the AHUM may be
obtained from Shire AG.
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